|
|
文章數:78 |
NINI 尼尼台中店家庭過節聚會適合嗎?》公益路人氣美食完整評比|10家一次破解 |
| 知識學習|考試升學 2026/04/21 07:14:14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
身為一個熱愛美食、喜歡在城市裡挖掘驚喜的人,臺中公益路一直是我最常出沒的地方之一。這條路可說是「臺中人的美食戰場」,從精緻西餐到創意火鍋,從日式丼飯到義式早午餐,每走幾步,就會有完全不同的特色料理餐廳。 這次我特別花了一整個月,實際造訪了公益路上十間口碑不錯的餐廳。有的是網友熱推的打卡名店,也有隱藏在巷弄裡的小驚喜。我以環境氛圍、口味表現、價格CP值與再訪意願為基準,整理出這篇實測評比。希望能幫正在猶豫去哪裡吃飯的你,找到那一間「吃完會想再來」的餐廳。 評比標準與整理方向
這次我走訪的10家餐廳橫跨不同料理類型,從高質感牛排館到巷弄系早午餐,每一間都有自己獨特的風格。為了讓整體比較更客觀,我依照以下四大面向進行評比,並搭配實際用餐體驗來打分。
整體而言,我希望這份評比不只是「哪家好吃」,而是幫你在不同情境下(約會、家庭聚餐、朋友小聚、商業午餐)都能快速找到合適的選擇。畢竟,美食不只是味覺的滿足,更是一段段與朋友共享的生活記憶。 10間臺中公益路餐廳評比懶人包公益路向來是臺中人聚餐的首選地段,從火鍋、燒肉到中式料理與早午餐,每走幾步就有驚喜。以下是我實際造訪過的10間代表性餐廳清單,橫跨平價、創意、高級各路風格。
一頭牛日式燒肉|炭香濃郁的和牛饗宴,約會聚餐首選
走在公益路上,很難不被 一頭牛日式燒肉 的木質外觀吸引。低調卻不失質感的門面,搭配昏黃燈光與暖色調的內裝,讓人一進門就感受到濃濃的日式職人氛圍。店內空間不大,但桌距規劃得宜,每桌皆設有獨立排煙設備,烤肉時完全不怕滿身油煙味。 餐點特色
一頭牛的靈魂,絕對是他們招牌的「三國和牛拼盤」。 用餐體驗整體節奏掌握得非常好。店員會在你剛想烤下一片肉時貼心遞上夾子、幫忙換烤網,讓人完全不用分心。整場用餐過程就像一場表演,從視覺、嗅覺到味覺都被滿足。 綜合評分
地址:408臺中市南屯區公益路二段162號電話:04-23206800 小結語一頭牛日式燒肉不僅是「吃肉的地方」,更像是一場五感盛宴。從進門那一刻到最後一道甜點,都能感受到他們對細節的用心。 TANG Zhan 湯棧|文青系火鍋代表,麻香湯底與視覺美感並重
在公益路這條美食戰線上,TANG Zhan 湯棧 是讓人一眼就會想走進去的那一種。 餐點特色
湯棧最有名的當然是它的「麻香鍋」。 用餐體驗整體氛圍比一般火鍋店更有質感。 綜合評分
地址:408臺中市南屯區公益路二段248號電話:04-22580617 官網:https://www.facebook.com/TangZhan.tw/ 小結語TANG Zhan 湯棧 把傳統火鍋做出新的樣貌保留臺式鍋物的溫度,又結合現代風格與細節服務,讓吃鍋這件事變得更有品味。 如果你想找一間兼具「好吃、好拍、好放鬆」的火鍋店,湯棧會是公益路上最有風格的選擇之一。 NINI 尼尼臺中店|明亮寬敞的義式早午餐天堂
如果說前兩間是肉食愛好者的天堂,那 NINI 尼尼臺中店 絕對是想放鬆、聊聊天的好地方。餐廳外觀以白色系與大片玻璃窗為主,陽光灑進室內,讓人一踏入就有種度假般的輕盈感。假日早午餐時段特別熱鬧,建議提早訂位。 餐點特色
NINI 的菜單融合義式與臺灣人口味,選擇多樣且份量十足。主打的 松露燉飯 濃郁卻不膩口,米芯保留微Q口感;而 香蒜海鮮義大利麵 則以新鮮白蝦、花枝與淡菜搭配微辣蒜香,口感層次豐富。 用餐體驗店內氣氛輕鬆不拘謹,無論是一個人帶電腦工作、或朋友聚餐,都能找到舒服角落。餐點上桌速度穩定,服務人員態度親切、補水與收盤都非常主動。整體節奏讓人覺得「時間變慢了」,很適合想遠離忙碌日常的人。 綜合評分
地址:40861臺中市南屯區公益路二段18號電話:04-23288498 小結語NINI 尼尼臺中店是一間能讓人放下手機、慢慢吃飯的餐廳。餐點不追求浮誇,而是以「剛剛好」的份量與風味,陪伴每個平凡午後。如果你在找一間能邊吃邊聊天、拍照也漂亮的早午餐店,NINI 會是你在公益路上最不費力的幸福選擇。 加分100%浜中特選昆布鍋物|平價卻用心的湯頭系火鍋,家庭聚餐好選擇
在公益路這條高質感餐廳林立的戰場上,加分100%浜中特選昆布鍋物 走的是截然不同的路線。它沒有浮誇的裝潢、也沒有高價位的套餐,但靠著實在的湯頭與親切的服務,默默吸引許多回頭客。每到用餐時間,總能看到家庭或情侶三兩成群地圍著鍋邊聊天。 餐點特色
主打 北海道浜中昆布湯底,湯頭清澈卻不單薄,越煮越能喝出海藻與柴魚的自然香氣。 用餐體驗整體氛圍偏家庭取向,桌距寬敞、座位舒適,帶小孩來也不覺擁擠。店員態度親切,補湯、收盤都很勤快,給人一種「被照顧著」的安心感。 綜合評分
地址:403臺中市西區公益路288號電話:0910855180 小結語加分100%浜中特選昆布鍋物是一間「不浮誇、但會讓人想再訪」的火鍋店。它不追求豪華擺盤,而是用最簡單的湯頭與新鮮食材,傳遞出家常卻不平凡的溫度。 印月餐廳|中式料理的藝術演繹,宴客與家庭聚會首選
說到臺中公益路的中式料理代表,印月餐廳 絕對是榜上有名。這間開業多年的餐廳以「中菜西吃」的概念聞名,把傳統中式料理以現代手法重新詮釋。從建築外觀到餐具擺設,每個細節都散發著低調的典雅氣息。 餐點特色
印月最令人印象深刻的是他們將傳統中菜融入創意手法。 用餐體驗服務方面完全對得起餐廳的高級定位。從入座、點餐到上菜節奏,都拿捏得恰如其分。每道菜都會有服務人員細心介紹食材與吃法,讓人感受到「被款待」的尊榮感。 綜合評分
地址:408臺中市南屯區公益路二段818號電話:0422511155 小結語印月餐廳是一間「不只吃飯,更像品味生活」的地方。 KoDō 和牛燒肉|極致職人精神,專為儀式感與頂級味覺而生
若要形容 KoDō 和牛燒肉 的用餐體驗,一句話足以總結——「像在欣賞一場關於肉的表演」。 餐點特色
這裡主打 日本A5和牛冷藏肉,以「精切厚燒」的方式呈現。 用餐體驗KoDō 的最大特色是「儀式感」。 綜合評分
地址:403臺中市西區公益路260號電話:0423220312 官網:https://www.facebook.com/kodo2018/ 小結語KoDō 和牛燒肉不是日常餐廳,而是一場體驗。 永心鳳茶|在茶香裡用餐的優雅時光,臺味早午餐的新詮釋
走進 永心鳳茶公益店,彷彿進入一間有氣質的茶館。 餐點特色
永心鳳茶的餐點結合中式靈魂與西式擺盤,無論是「炸雞腿飯」還是「紅玉紅茶拿鐵」,都能讓人感受到熟悉卻不平凡的味道。 用餐體驗店內服務人員態度溫和,對茶品介紹詳盡。上餐節奏剛好,不急不徐。 綜合評分
地址:40360臺中市西區公益路68號三樓(勤美誠品)電話:0423221118 小結語永心鳳茶讓人重新定義「臺味」。 三希樓|老饕級江浙功夫菜,穩重又帶人情味的中式饗宴
位於公益路上的 三希樓 是許多臺中老饕的口袋名單。 餐點特色
三希樓的菜色以 江浙與港式料理 為主,兼顧傳統與現代風味。 用餐體驗三希樓的服務給人一種老派但貼心的感覺。 綜合評分
地址:408臺中市南屯區公益路二段95號電話:0423202322 官網:https://www.sanxilou.com.tw/ 小結語三希樓是一間「吃得出功夫」的餐廳。 一笈壽司|低調奢華的無菜單日料,職人手藝詮釋旬味極致
在熱鬧的公益路上,一笈壽司 低調得幾乎不顯眼。 餐點特色
一笈壽司採 Omakase(無菜單料理) 形式,每一餐都由主廚根據當日食材設計。 用餐體驗整場用餐約90分鐘,節奏緩慢但沉穩。 綜合評分
地址:408臺中市南屯區公益路二段25號電話:0423206368 官網:https://www.facebook.com/YIJI.sushi/ 小結語一笈壽司是一間真正讓人「放慢呼吸」的餐廳。 茶六燒肉堂|人氣爆棚的和牛燒肉聖地,肉香與幸福感同時滿分
若要票選公益路上「最難訂位」的餐廳,茶六燒肉堂 絕對名列前茅。 餐點特色
茶六主打 和牛燒肉套餐,價格約落在 $700–$1000 間,份量與品質兼具。 用餐體驗茶六的服務效率相當高。店員親切、換網勤快、補水速度快,整場用餐流程流暢無壓力。 綜合評分
地址:403臺中市西區公益路268號電話:0423281167 官網:https://inline.app/booking/-L93VSXuz8o86ahWDRg0:inline-live-karuizawa/-LUYUEIOYwa7GCUpAFWA 小結語茶六燒肉堂用「穩定品質+輕奢氛圍」抓住了臺中年輕族群的心。 吃完10家公益路餐廳後的心得與結語吃完這十家餐廳後,臺中公益路不只是一條美食街,而是一段生活風景線。 有的餐廳講究細膩與儀式感,像 一頭牛日式燒肉 與 一笈壽司,讓人感受到食材最純粹的美好 有的則以親切與溫度打動人心,像 加分昆布鍋物、永心鳳茶,讓人明白吃飯不只是為了飽足,而是一種被照顧的幸福。 而像茶六燒肉堂、TANG Zhan 湯棧 這類人氣名店,則用穩定的品質與熱絡的氛圍,成為許多臺中人心中「想吃肉就去那裡」的代名詞。 這十家店,構成了公益路最動人的縮影 有華麗的,也有溫柔的;有傳統的,也有創新的。 每一家都在自己的風格裡發光,讓人吃到的不只是料理,而是一種生活的溫度與節奏。 對我而言,這不僅是一場美食旅程,更是一趟關於「臺中味道」的回憶之旅。 FAQ:關於臺中公益路美食常見問題Q1:公益路哪一區的餐廳最集中? Q2:需要提前訂位嗎? 最後的話若要用一句話形容這趟美食之旅,我會說: 印月餐廳海鮮表現如何? 如果你也和我一樣喜歡用味蕾探索一座城市,那就把這篇公益路美食攻略收藏起來吧。NINI 尼尼臺中店氣氛如何? 無論是約會、慶生、家庭聚餐,或只是想犒賞一下辛苦的自己——這條路上永遠會有一間剛剛好的餐廳在等你。三希樓商務聚餐適合嗎? 下一餐,不妨從這10家開始。茶六燒肉堂尾牙聚餐表現如何? 打開手機、約上朋友,讓公益路成為你生活裡最容易抵達的小確幸。印月餐廳用餐環境舒服嗎? 如果你有私心愛店,也歡迎留言分享,KoDō 和牛燒肉網路評價符合期待嗎? 你的推薦,可能讓我下一趟美食旅程變得更精彩。NINI 尼尼臺中店網路評價符合期待嗎? Researchers have discovered a new deep-sea bacterial strain, Poriferisphaera hetertotrophicis, which is unique for its budding division model and plays a significant role in nitrogen assimilation. The bacteria also live symbiotically with a bacteriophage that further facilitates nitrogen metabolism. (Artist’s concept) Researchers have discovered a new species of marine bacteria that reproduces through a unique budding process and releases viruses to facilitate nitrogen metabolism. Researchers have isolated a new strain of marine bacteria with unique characteristics from the ocean seabed. The study, recently published in the journal eLife, is hailed by the editors as a significant contribution to our grasp of the physiological processes within deep-sea Planctomycetes bacteria. It highlights unique attributes, including its singular method of cell division, which sets it apart as the only known species in the class of Phycisphaerae bacteria that uses a distinct budding model of division. It provides what the editors also say is convincing evidence that the new species is extensively involved in nitrogen assimilation and lives with a chronic virus (bacteriophage) that facilitates nitrogen metabolism. Nitrogen cycling by bacteria is an essential process that frees up nitrogen for building into nucleic acids, amino acids, and proteins – the building blocks of life. “Until recently, most research on the Planctomycetes family of bacteria has focused on strains in freshwater and shallow ocean environments, because of the logistical difficulties associated with sampling and cultivating deep-sea strains,” says lead author Rikuan Zheng, a research associate at the Institute of Oceanology, Chinese Academy of Sciences, Beijing, China, and the National Laboratory for Marine Science and Technology, Qingdao, China. “Most Planctomycetes bacteria have been isolated using growth media that are nutritionally poor, so we wanted to see if using a nutrient-rich medium would make it possible to culture and further characterize members of this poorly understood family.” A novel bacteria, Poriferisphaera hetertotrophicis, observed using Transmission Electron Microscopy (TEM). Abbreviations: CM, outer membrane; Pi, cytoplasm; R, ribosome; N, nucleoid; ICM, cytoplasmic membrane; Py, peripla. Credit: Rikuan Zheng Isolation and Identification of Poriferisphaera hetertotrophicis To isolate the novel bacterium, the team took sediment samples from a deep-sea cold seep, where Planctomycetes bacteria are known to reside, and then encouraged their growth by supplementing a standard growth medium with the antibiotic rifampicin and sources of nitrogen. They cultured these enriched bacteria on agar and evaluated individual colonies further by gene sequencing. Among the bacteria, they identified a strain called ZRK32 that grew faster than others, and looked likely to be a member of the genus Poriferisphaera. To confirm this, the team compared the genetic similarities between this strain and other members of the Poriferisphaera genus and found that it was distinguishable from Poriferisphaera corsica, the only other species with a valid published name. This suggests that ZRK32 is a novel species – which the team proposes to call Poriferisphaera hetertotrophicis. To learn more about this new species, the team studied its growth and how it multiplies. They found that, unlike other Planctomycetes family members, Poriferisphaera hetertotrophicis grows better in nutrient-rich media and multiplies via a budding mechanism, where parent cells create outgrowth buds that develop into daughter cells. Nitrogen Influences Growth and Viral Activation As the Planctomycetes bacteria family is known to play an important role in nitrogen cycling, the team next explored whether this was also the case for Poriferisphaera hetertotrophicis. To test this, they looked at the effects of different nitrogen-containing substances – nitrates, ammonia, and nitrogen dioxide – on Poriferisphaera hetertotrophicis growth. They found that adding nitrogen in the form of a nitrate or ammonia increased growth, whereas adding it as a nitrite inhibited growth. They also discovered that the addition of nitrate or ammonia caused the novel strain to release a bacteriophage – a type of virus that infects bacteria. Bacteriophages are widely distributed across oceans and can regulate nitrogen metabolism in their host bacteria. This bacteriophage – called phage-ZRK32 – was able to increase the growth of Poriferisphaera hetertotrophicis and other marine bacteria dramatically by facilitating nitrogen metabolism. Even though the team’s genetic analysis suggested Poriferisphaera hetertotrophicis contains all the necessary genes for metabolizing nitrate and ammonia, chronic infection with this bacteriophage may help to further optimize nitrogen metabolism. “Our analyses indicate that strain ZRK32 is a novel species, which grows best in nutrient-rich media and releases a bacteriophage in the presence of nitrogen,” concludes senior author Chaomin Sun, a Professor at the Institute of Oceanology, Chinese Academy of Sciences, and the National Laboratory for Marine Science and Technology. “This phage-ZRK32 is a chronic bacteriophage that lives within its host without killing it. Our findings provide a novel insight into nitrogen metabolism in Planctomycetes bacteria and a suitable model to study the interactions between Planctomycetes and viruses.” Reference: “Physiological and metabolic insights into the first cultured anaerobic representative of deep-sea Planctomycetes bacteria” by Rikuan Zheng, Chong Wang, Rui Liu, Ruining Cai and Chaomin Sun, 28 August 2023, eLife. DOI: 10.7554/eLife.89874.1 The Human Microbiome Project, which was launched by NIH in 2007, provided the first glimpse of the microbial diversity of healthy humans and is exploring the possible relationships between particular human diseases and the microbiome. (Clockwise from top left): Streptococcus (Credit: Tom Schmidt); microbial biofilm, of mixed species, from the human body (credit: A. Earl, Broad Institute/MIT); Bacillus (Credit: Tom Schmid); Malassezia lopophilis (Credit: J.H, CDC). For composite image: Jonathan Bailey, National Human Genome Research Institute, NIH New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the Antarctic desert soil. Since the recent pandemic, our use of disinfectants has surged, but could our push for sterile urban environments be backfiring? A new study published in the journal Microbiome has identified novel strains of microbes that have adapted to use the limited resources available in cities and shown that our everyday behavior is changing the makeup of microorganisms in indoor environments. “Built environments offer distinct conditions that set them apart from natural and engineered habitats,” says Dr. Xinzhao Tong, an assistant professor at Xi’an Jiaotong-Liverpool University (XJTLU), China, and lead author of the study. “Areas with many buildings are low in the traditional nutrients and essential resources microbes need for survival, so these built environments have a unique microbiome. “Our use of cleaning and other manufactured products creates a unique setting that puts selective pressures on microbes, which they must adapt to or be eliminated, but the mechanisms by which microbes adapt and survive in built environments are poorly understood,” Dr. Tong explains. City dwellers The researchers collected 738 samples from a variety of built environments, including subways, residences, public facilities, piers, and human skin in Hong Kong. They then used shotgun metagenomic sequencing to analyze the microbes’ genomic content and understand how they have adapted to the challenging urban conditions. The team identified 363 microbial strains that have not been previously identified that live on our skin and the environment around us. Some of these strains’ genomes contained genes for metabolizing manufactured products found in cities and using them as carbon and energy sources. This includes the discovery of a strain of Candidatus phylum Eremiobacterota, previously only reported in Antarctic desert soil. Specialized metabolic capacities of microbes in oligotrophic built environments. Tong et al. “Diverse and specialized metabolic capabilities of microbes in oligotrophic built environments.” Microbiome (2024). Credit: AJE Video Bytes, in partnership with Springer Nature Group Dr Tong says: “The genome of this novel strain of Eremiobacterota enables it to metabolize ammonium ions found in cleaning products. The strain also has genes for alcohol and aldehyde dehydrogenases to break down residual alcohol found in common disinfectants. “Microbes possessing enhanced capabilities to utilize limited resources and tolerate manufactured products, such as disinfectants and metals, out-compete non-resistant strains, enhancing their survival and even evolution within built environments. They could, therefore, pose health risks if they are pathogenic.” The team identified 11 unique, previously uncharacterized strains of Micrococcus luteus, typically non-pathogenic but capable of causing opportunistic infections in immunocompromised individuals. “The issue of their adaptation to our behavior becomes particularly critical in clinical settings where hospitals serve as hotspots for diverse pathogens that cause hospital-acquired infections (HAIs). HAIs pose a significant threat, particularly in intensive care units where mortality rates can reach up to 30%,” says Dr Tong. A balancing act The researchers also characterized two novel strains of Patescibacteria, known as “nanobacteria”, as they have tiny genomes that do not contain many genes for producing their own resources. Dr Tong says: “Some strains of Patescibacteria are considered parasitic as they rely on bacterial hosts to supply their nutrients. However, in this study, the researchers found that one of the nanobacteria strains, recovered from human skin, contains genes for the biosynthesis of carotenoids and ubiquinone. These antioxidant compounds are vital to humans, and we typically acquire them, especially carotenoids, through our diets, suggesting a possible mutualistic relationship between bacteria and us as their hosts.” This enhanced understanding of microbial metabolic functions within built environments helps develop strategies to create a healthy indoor ecosystem of microbes for us to live alongside. The team is now investigating the transmission and evolution of resistance in pathogenic microbes in intensive care units that are exposed to stringent and extensive disinfectant practices. They hope to improve infection control practices and increase the safety of clinical environments for healthcare workers and patients. Reference: “Diverse and specialized metabolic capabilities of microbes in oligotrophic built environments” by Xinzhao Tong, Danli Luo, Marcus H. Y. Leung, Justin Y. Y. Lee, Zhiyong Shen, Wengyao Jiang, Christopher E. Mason and Patrick K. H. Lee, 17 October 2024, Microbiome. DOI: 10.1186/s40168-024-01926-6 Funding: Hong Kong Research Grants Council Research Impact 642 Fund, Natural Science Foundation of Jiangsu Province, Hong Kong Research Grants Council General Research Fund Researchers have identified a link between the antiviral drug molnupiravir and specific mutations in the SARS-CoV-2 virus. While molnupiravir is designed to induce mutations to weaken the virus, the study found distinct mutation patterns in individuals who had taken the drug. These mutations were especially prevalent among older populations and in areas with high molnupiravir consumption. A study found a connection between the antiviral drug molnupiravir and distinct SARS-CoV-2 mutations, emphasizing the need for careful assessment in drug development. Researchers at the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town, and the The UK Health Security Agency (UKHSA) have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus. Molnupiravir works by inducing mutations in the virus’s genetic information, or genome, during replication. Many of these mutations will damage or kill the virus, reducing viral load in the body. It was one of the first antivirals available on the market during the COVID-19 pandemic and was widely adopted by many countries. In research published in Nature today (September 25), the scientists used global sequencing databases to map mutations in the SARS-CoV-2 virus over time. They analyzed a family tree of 15 million SARS-CoV-2 sequences so that at each point in each virus’s evolutionary history they could see which mutations had occurred. Unusual Mutation Patterns Although viruses mutate all the time, the researchers identified mutational events in the global sequencing database which looked very different to typical patterns of COVID-19 mutations, and that they were strongly associated with individuals who had taken molnupiravir. These mutations increased in 2022, coinciding with the introduction of molnupiravir. They were also more likely to be seen in older age groups, consistent with the use of the antivirals to treat people who are more at risk, and in countries that are known to have high molnupiravir use. In England, the researchers analyzed treatment data and found that at least 30% of the events involved use of molnupiravir. Comparison between the global sequencing database and the data from known datasets of molnupiravir-treated patients shows the same pattern of mutations in both (C to T and G to A mutations). Credit: Theo Sanderson, Nature (2023). The causes of mutational events can be traced by looking at their ‘mutational signature’: a preference for mutations to occur at particular sequences in the genome. The researchers found a close match between the signature seen in these mutational events and the signature in clinical trials of molnupiravir. The researchers also saw small clusters of mutations which suggests onward transmission from one person to another, although no established variants of concern are currently linked to this signature. Implications and Expert Insights Understanding the impact of molnupiravir treatment on the risks of new variants, and any impact they might have on public health is difficult. It is also important to consider that chronic COVID-19 infections, which molnupiravir is used for, can themselves result in new mutations. Theo Sanderson, lead author and postdoctoral researcher at the Francis Crick Institute, said: “COVID-19 is still having a major effect on human health, and some people have difficulty clearing the virus, so it’s important we develop drugs that aim to cut short the length of infection. But our evidence shows that a specific antiviral drug, molnupiravir, also results in new mutations, increasing the genetic diversity in the surviving viral population. “Our findings are useful for ongoing assessment of the risks and benefits of molnupiravir treatment. The possibility of persistent antiviral-induced mutations needs to be taken into account for the development of new drugs that work in a similar way. Our work shows that the unprecedented size of post-pandemic sequence datasets, collaboratively built by thousands of researchers and healthcare workers around the world, creates huge power to reveal insights into virus evolution that would not be possible from analysis of data from any individual country.’” Christopher Ruis from the Department of Medicine at the University of Cambridge, said: “Molnupiravir is one of a number of drugs being used to fight COVID-19. It belongs to a class of drugs that can cause the virus to mutate so much that it is fatally weakened. But what we’ve found is that in some patients, this process doesn’t kill all the viruses, and some mutated viruses can spread. This is important to take into account when assessing the overall benefits and risks of molnupiravir and similar drugs.” Reference: “A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes” by Theo Sanderson, Ryan Hisner, I’ah Donovan-Banfield, Hassan Hartman, Alessandra Løchen, Thomas P. Peacock and Christopher Ruis, 25 September 2023, Nature. DOI: 10.1038/s41586-023-06649-6 RRG455KLJIEVEWWF |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 最新創作 |
|
||||
|
||||
|
||||
|
||||
|
||||



























